File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Initial experience with Temporary Implantable Nitinol Device (TIND) for benign prostatic hyperplasia

TitleInitial experience with Temporary Implantable Nitinol Device (TIND) for benign prostatic hyperplasia
Authors
Issue Date2019
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/
Citation
The 23rd Hong Kong Urological Assoication Annual Scientific Meeting, Hong Kong, 4 November 2018. In BJU International, v. 123 n. S1, p. 13 How to Cite?
AbstractObjectives: To determine whether there is improvement in IPSS and uroflowmetry parameters in BPH patients who underwent TIND insertion and whether significant side effects were encountered in these patients Patient and Methods: All male patients with symptomatic BPH with prostate volume <75 mL were eligible for TIND insertion. Patient with a history of previous prostate surgery, non‐BPH causes of LUTS, post‐void residual >250 mL, impaired renal function, or active malignancy were excluded from the study. Demographic, baseline characteristics, pre‐insertion assessment and post‐insertion follow up were performed at 3, 6, 12 months. IPSS, uroflowmetry, sexual function, and adverse events were assessed on each follow up. Results: A total of 7 patients were inserted with TIND. Mean age of the patients were 69 years old. Mean pre‐operative Qmax was 9.7 mL/s. Mean Qmax improvement at 3 and 12 months were 4.0 mL/s and 4.2 mL/s, respectively. Mean IPSS improvement at 3 and 12 months were 11 pts and 4.7pts, respectively. One patient had deterioration of symptoms despite TIND and required TURP to be performed within 12 months of insertion. Conclusions: Initial experience with TIND for LUTS due to BPH is encouraging with satisfactory results within the first year of insertion.
DescriptionPoster Presentation
Persistent Identifierhttp://hdl.handle.net/10722/266489
ISSN
2017 Impact Factor: 4.688
2015 SCImago Journal Rankings: 2.009

 

DC FieldValueLanguage
dc.contributor.authorHo, SHB-
dc.contributor.authorWong, KWC-
dc.contributor.authorTsang, CF-
dc.contributor.authorLai, TCT-
dc.contributor.authorNg, ATL-
dc.contributor.authorMa, WK-
dc.contributor.authorTsu, HLJ-
dc.date.accessioned2019-01-18T08:20:38Z-
dc.date.available2019-01-18T08:20:38Z-
dc.date.issued2019-
dc.identifier.citationThe 23rd Hong Kong Urological Assoication Annual Scientific Meeting, Hong Kong, 4 November 2018. In BJU International, v. 123 n. S1, p. 13-
dc.identifier.issn1464-4096-
dc.identifier.urihttp://hdl.handle.net/10722/266489-
dc.descriptionPoster Presentation-
dc.description.abstractObjectives: To determine whether there is improvement in IPSS and uroflowmetry parameters in BPH patients who underwent TIND insertion and whether significant side effects were encountered in these patients Patient and Methods: All male patients with symptomatic BPH with prostate volume <75 mL were eligible for TIND insertion. Patient with a history of previous prostate surgery, non‐BPH causes of LUTS, post‐void residual >250 mL, impaired renal function, or active malignancy were excluded from the study. Demographic, baseline characteristics, pre‐insertion assessment and post‐insertion follow up were performed at 3, 6, 12 months. IPSS, uroflowmetry, sexual function, and adverse events were assessed on each follow up. Results: A total of 7 patients were inserted with TIND. Mean age of the patients were 69 years old. Mean pre‐operative Qmax was 9.7 mL/s. Mean Qmax improvement at 3 and 12 months were 4.0 mL/s and 4.2 mL/s, respectively. Mean IPSS improvement at 3 and 12 months were 11 pts and 4.7pts, respectively. One patient had deterioration of symptoms despite TIND and required TURP to be performed within 12 months of insertion. Conclusions: Initial experience with TIND for LUTS due to BPH is encouraging with satisfactory results within the first year of insertion.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/-
dc.relation.ispartofBJU International-
dc.rightsPreprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Postprint This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.titleInitial experience with Temporary Implantable Nitinol Device (TIND) for benign prostatic hyperplasia-
dc.typeConference_Paper-
dc.identifier.emailHo, SHB: hobrian@hku.hk-
dc.identifier.emailWong, KWC: kwwongab@HKUCC-COM.hku.hk-
dc.identifier.emailNg, ATL: ada5022@hku.hk-
dc.identifier.emailMa, WK: mwk054@hku.hk-
dc.identifier.emailTsu, HLJ: jamestsu@hku.hk-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1111/bju.14677-
dc.identifier.hkuros296746-
dc.identifier.volume123-
dc.identifier.issueS1-
dc.identifier.spage13-
dc.identifier.epage13-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats